A recently published clinical case of a patient with lung cancer and probable asthma–chronic obstructive pulmonary syndrome overlap syndrome reported that this patient presented worsened lung condition when subjected to immunotherapy with anti-PD-L1 durvalumab. Here, CD274 is linked to lung cancer.